英文别名Bufarenogin; 3β,12α,14-Trihydroxy-11-oxo-5β-bufa-20,22-dienolide; Pseudobufarenogenin; pseudo-Bufarenogenin; Bufa-20,22-dienolide,3,12,14-trihydroxy-11-oxo-, (3b,5b,12a)-; psi-Bufarenogin; (3-beta,5-beta,12-alpha)-11-Oxo-3,12,14-trihydroxybufa-20,22-dienolide; Bufa-20,22-dienolide, 11-oxo-3,12,14-trihydroxy-, (3-beta,5-beta,12-alpha)-; 5-beta-Bufa-20,22-dienolide, 3-beta,12-alpha,14-trihydroxy-11-oxo-; 11-oxo-3beta,12alpha,14beta-trihydroxy-5beta-bufa-20,22-dienolide; 5beta-Bufa-20,22-dienolide, 3beta,12alpha,14-trihydroxy-11-oxo-; 3beta,12alpha,14-Trihydroxy-11-oxo-5beta-bufa-20,22-dienolide; (3beta,5beta,12alpha)-3,12,14-Trihydroxy-11-oxobufa-20,22-dienolide; Bufa-20,22-dienolide, 3,12,14-trihydroxy-11-oxo-, (3beta,5beta,12alpha)-; 5-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one; phi-bufarenogin; I-Bufarenogin 
